Hip implants are intended to provide you with enhanced joint function and relief from pain. However, when the procedure is performed with a dangerous product – like the Stryker Corporation’s Rejuvenate Modular Primary Hip System – you may instead be faced with serious medical complications. When this occurs, our personal injury lawyers in Miami at Goldberg & Rosen will work relentlessly on your behalf – holding the manufacturer accountable and ensuring you receive the compensation you deserve.
The Stryker Rejuvenate Modular Primary Hip System was designed to allow surgeons to customize the implant to match any patient’s unique anatomy. It is composed of a neck component and a femoral stem, both of which come in a variety of sizes. The neck is composed of heavy metal cobalt and chromium, while the stem features a titanium coating.
The system was most commonly used to correct hip joint failure due to:
- Osteoarthritis, avascular necrosis and other non-inflammatory degenerative joint diseases.
- Rheumatoid arthritis.
- A functional deformity.
- A prior failed hip replacement.
- Fractures of the proximal femur.
In 2008, the Stryker Rejuvenate Modular Hip System achieved FDA-approval. However, it was with a provision that allowed the manufacturer to bypass the required pre-market clinical safety testing by demonstrating that the product is similar enough to another product that has already been approved.
Once patients began receiving the implants, complaints began to surface about serious injuries. As such, in April 2012 Stryker issued an Urgent Field Safety Notice for Corrective Action for the Rejuvenate modular stems and necks. In the notice, it updated the instructions for use of the Rejuvenate system due to the potential for corrosion and heavy metal toxicity. In June 2012, Stryker issued a voluntary recall of its hip implants due to the heightened risks associated with corrosion at the neck junction.
